CDK Global Analysts Recommendations and Consensus

CDK -- USA Stock  

USD 50.17  0.07  0.00%

The current analyst and expert consensus on CDK Global is Hold with 0 strong sell and 2 strong buy opinions. The current projected target price consensus is 68.33 with 3 analysts opinions. The most common way CDK Global analysts use to provide recommendation to public is financial statements analysis. Many experts also interview CDK Global executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on CDK Global. We strongly encourage you to use your own analysis of CDK Global to validate this buy or sell advice. CDK Global buy or sell recommendation module provides average expert sentiment on the projected CDK Global target price to derive its highest and lowest estimates based on projected price volatility of 2.886. Check also Macroaxis Advice on CDK Global to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

CDK Global Target Price Consensus

Number of Opinions5
Lowered Outlook0
Raized Outlook0
Hold
Macroaxis Recommendation   Exposure   Valuation

CDK Global Target Price Projection

Current Price

CDK Global Market Quote

Low Price48.02Odds
High Price50.46Odds

50.17

Target Price

Analyst Consensus On Target Price

Low Estimate65.0Odds
High Estimate70.0Odds
Number of Analysts3
Standard Deviation2.886

68.333

CDK Global Analysit Ratings

Average Consensus

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Current Thematic Trending

Real Goods Solar
Purchased few shares
Traded 3 days ago for 0.52
Pharmaceutical Products
Purchased over 90 shares
Traded 3 days ago for 0.13
Synergy Pharmaceuticals
Purchased few shares
Traded 3 days ago for 0.24
Vital Therapies
Purchased over 500 shares
Traded 3 days ago for 0.26
Pharmaceutical Products
Purchased over 100 shares
Traded 3 days ago for 0.13
Top Penny
Purchased over 100 shares
Traded 3 days ago for 0.8
Check also Macroaxis Advice on CDK Global to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon. Please also try Bollinger Bands module to use bollinger bands indicator to analyze target price for a given investing horizon.
Search macroaxis.com